These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22902052)

  • 1. Towards an empowerment approach in tuberculosis treatment in Cape Town, South Africa: a qualitative analysis of programmatic change.
    Atkins S; Lewin S; Ringsberg KC; Thorson A
    Glob Health Action; 2012 Aug; 5():1-11. PubMed ID: 22902052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An integrated community TB-HIV adherence model provides an alternative to DOT for tuberculosis patients in Cape Town.
    Kaplan R; Caldwell J; Hermans S; Adriaanse S; Mtwisha L; Bekker LG; Jennings K; Wood R
    Int J Tuberc Lung Dis; 2016 Sep; 20(9):1185-91. PubMed ID: 27510244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferential adherence to antiretroviral therapy over tuberculosis treatment: a qualitative study of drug-resistant TB/HIV co-infected patients in South Africa.
    Daftary A; Padayatchi N; O'Donnell M
    Glob Public Health; 2014; 9(9):1107-16. PubMed ID: 25035943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bridging the gap between policy and practice: a qualitative analysis of providers' field experiences tinkering with directly observed therapy in patients with drug-resistant tuberculosis in Addis Ababa, Ethiopia.
    Mussie KM; Gradmann C; Manyazewal T
    BMJ Open; 2020 Jun; 10(6):e035272. PubMed ID: 32554739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TB patients' perspectives on integrated TB/HIV services in South Africa.
    Levin L; Irving K; Dikgang M; Punwasi J; Isaacs M; Myer L
    Trop Doct; 2006 Jul; 36(3):173-5. PubMed ID: 16884629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes and implementation challenges of using daily treatment regimens with an innovative adherence support tool among HIV-infected tuberculosis patients in Karnataka, India: a mixed-methods study.
    Thekkur P; Kumar AN; Chinnakali P; Selvaraju S; Bairy R; Singh AR; Nirgude A; Selvaraj K; Venugopal V; Shastri S
    Glob Health Action; 2019; 12(1):1568826. PubMed ID: 30712507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Social constraints to TB/HIV healthcare: accounts from coinfected patients in South Africa.
    Daftary A; Padayatchi N
    AIDS Care; 2012; 24(12):1480-6. PubMed ID: 22530855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful integration of tuberculosis and HIV treatment in rural South Africa: the Sizonq'oba study.
    Gandhi NR; Moll AP; Lalloo U; Pawinski R; Zeller K; Moodley P; Meyer E; Friedland G;
    J Acquir Immune Defic Syndr; 2009 Jan; 50(1):37-43. PubMed ID: 19295333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilot evaluation of a second-generation electronic pill box for adherence to Bedaquiline and antiretroviral therapy in drug-resistant TB/HIV co-infected patients in KwaZulu-Natal, South Africa.
    Bionghi N; Daftary A; Maharaj B; Msibi Z; Amico KR; Friedland G; Orrell C; Padayatchi N; O'Donnell MR
    BMC Infect Dis; 2018 Apr; 18(1):171. PubMed ID: 29642874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The case for integrating tuberculosis and HIV treatment services in South Africa.
    Wood R
    J Infect Dis; 2007 Dec; 196 Suppl 3():S497-9. PubMed ID: 18181700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to Antiretroviral Therapy and Tuberculosis Treatment in a Prison of Tehran, Iran.
    Seyed Alinaghi SA; Farhoudi B; Mohraz M; Alipour A; Golrokhy R; Hosseini M; Miri J
    Infect Disord Drug Targets; 2016; 16(3):199-203. PubMed ID: 27311561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Directly observed therapy for treating tuberculosis.
    Karumbi J; Garner P
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD003343. PubMed ID: 26022367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of HIV status and antiretroviral treatment on TB treatment outcomes of new tuberculosis patients attending co-located TB and ART services in South Africa: a retrospective cohort study.
    Nglazi MD; Bekker LG; Wood R; Kaplan R
    BMC Infect Dis; 2015 Nov; 15():536. PubMed ID: 26584607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing treatment default among tuberculosis patients in a high burden province of South Africa.
    Kigozi G; Heunis C; Chikobvu P; Botha S; van Rensburg D
    Int J Infect Dis; 2017 Jan; 54():95-102. PubMed ID: 27894985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. It's complicated: why do tuberculosis patients not initiate or stay adherent to treatment? A qualitative study from South Africa.
    Skinner D; Claassens M
    BMC Infect Dis; 2016 Nov; 16(1):712. PubMed ID: 27887646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards understanding the drivers of policy change: a case study of infection control policies for multi-drug resistant tuberculosis in South Africa.
    Saidi T; Salie F; Douglas TS
    Health Res Policy Syst; 2017 May; 15(1):41. PubMed ID: 28558838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal trends in TB notification rates during ART scale-up in Cape Town: an ecological analysis.
    Hermans S; Boulle A; Caldwell J; Pienaar D; Wood R
    J Int AIDS Soc; 2015; 18(1):20240. PubMed ID: 26411694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to Concurrent Tuberculosis Treatment and Antiretroviral Treatment among Co-Infected Persons in South Africa, 2008-2010.
    Webb Mazinyo E; Kim L; Masuku S; Lancaster JL; Odendaal R; Uys M; Podewils LJ; Van der Walt ML
    PLoS One; 2016; 11(7):e0159317. PubMed ID: 27442440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wirelessly observed therapy compared to directly observed therapy to confirm and support tuberculosis treatment adherence: A randomized controlled trial.
    Browne SH; Umlauf A; Tucker AJ; Low J; Moser K; Gonzalez Garcia J; Peloquin CA; Blaschke T; Vaida F; Benson CA
    PLoS Med; 2019 Oct; 16(10):e1002891. PubMed ID: 31584944
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.